Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
Human cytomegalovirus (HCMV), a ubiquitous beta-herpesvirus, is able to establish lifelong latency after initial infection. Periodical reactivation occurs after immunosuppression, remaining a major cause of death in immunocompromised patients. HCMV has to reach a structural and functional balance wi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.01511/full |
id |
doaj-9df0df9212104c228807a98318fcbd25 |
---|---|
record_format |
Article |
spelling |
doaj-9df0df9212104c228807a98318fcbd252020-11-25T02:37:15ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2020-07-011110.3389/fmicb.2020.01511547050Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried MoleculesYu-Qing Wang0Yu-Qing Wang1Xiang-Yu Zhao2Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, ChinaPKU-THU Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, ChinaPeking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, ChinaHuman cytomegalovirus (HCMV), a ubiquitous beta-herpesvirus, is able to establish lifelong latency after initial infection. Periodical reactivation occurs after immunosuppression, remaining a major cause of death in immunocompromised patients. HCMV has to reach a structural and functional balance with the host at its earliest entry. Virion-carried mediators are considered to play pivotal roles in viral adaptation into a new cellular environment upon entry. Additionally, one clear difference between primary infection and reactivation is the idea that virion-packaged factors are already formed such that those molecules can be used swiftly by the virus. In contrast, virion-carried mediators have to be transcribed and translated; thus, they are not readily available during reactivation. Hence, understanding virion-carried molecules helps to elucidate HCMV reactivation. In this article, the impact of virion-packaged molecules on viral structure, biological behavior, and viral life cycle will be reviewed.https://www.frontiersin.org/article/10.3389/fmicb.2020.01511/fullHCMVvirion-carried moleculesprimary infectionreactivationtegumentenvelope |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu-Qing Wang Yu-Qing Wang Xiang-Yu Zhao |
spellingShingle |
Yu-Qing Wang Yu-Qing Wang Xiang-Yu Zhao Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules Frontiers in Microbiology HCMV virion-carried molecules primary infection reactivation tegument envelope |
author_facet |
Yu-Qing Wang Yu-Qing Wang Xiang-Yu Zhao |
author_sort |
Yu-Qing Wang |
title |
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules |
title_short |
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules |
title_full |
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules |
title_fullStr |
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules |
title_full_unstemmed |
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules |
title_sort |
human cytomegalovirus primary infection and reactivation: insights from virion-carried molecules |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Microbiology |
issn |
1664-302X |
publishDate |
2020-07-01 |
description |
Human cytomegalovirus (HCMV), a ubiquitous beta-herpesvirus, is able to establish lifelong latency after initial infection. Periodical reactivation occurs after immunosuppression, remaining a major cause of death in immunocompromised patients. HCMV has to reach a structural and functional balance with the host at its earliest entry. Virion-carried mediators are considered to play pivotal roles in viral adaptation into a new cellular environment upon entry. Additionally, one clear difference between primary infection and reactivation is the idea that virion-packaged factors are already formed such that those molecules can be used swiftly by the virus. In contrast, virion-carried mediators have to be transcribed and translated; thus, they are not readily available during reactivation. Hence, understanding virion-carried molecules helps to elucidate HCMV reactivation. In this article, the impact of virion-packaged molecules on viral structure, biological behavior, and viral life cycle will be reviewed. |
topic |
HCMV virion-carried molecules primary infection reactivation tegument envelope |
url |
https://www.frontiersin.org/article/10.3389/fmicb.2020.01511/full |
work_keys_str_mv |
AT yuqingwang humancytomegalovirusprimaryinfectionandreactivationinsightsfromvirioncarriedmolecules AT yuqingwang humancytomegalovirusprimaryinfectionandreactivationinsightsfromvirioncarriedmolecules AT xiangyuzhao humancytomegalovirusprimaryinfectionandreactivationinsightsfromvirioncarriedmolecules |
_version_ |
1724795838025170944 |